Real-time enrollment status for this bladder cancer clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 1:39 PM UTC
| NCT Number | NCT06305767 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Bladder Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 230 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | January 13, 2026 (Jan 13, 2026) |
As of March 2, 2026: Clinical trial NCT06305767 is currently active_not_recruiting participants. This clinical trial study for bladder cancer is not currently accepting new participants at 10 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06305767 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06305767 was last updated Jan 13, 2026 (January 13, 2026). HelloStudys verifies this status automatically.